Entry Detail



General Information

Database ID:exR0075949
RNA Name:LAPTM5
RNA Type:mRNA
Chromosome:chr1
Starnd:-
Coordinate:
Start Site(bp):30732469End Site(bp):30757774
External Links:ENSG00000162511



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABHD2
chr15
89087459
89202355
+
AC004922.1
chr7
99325879
99394653
+
AC007192.1
chr19
18153158
18178117
+
AC009690.3
chr15
72266746
72319946
-
AC010422.3
chr19
12643831
12648397
-
AC015813.2
chr17
57989038
58007246
-
AC069503.2
chr12
121888809
121921470
+
AC104452.1
chr3
49416777
49429314
-
AC104472.3
chr3
155763043
155854442
-
AC118549.1
chr1
77562416
77683419
-
ACAT2
chr6
159762045
159779112
+
ACO1
chr9
32384603
32454769
+
ACTA1
chr1
229431245
229434098
-
ACTB
chr7
5527148
5563784
-
ACTG1
chr17
81509971
81523847
-
AGPAT1
chr6
32168212
32178096
-
AHCY
chr20
34280268
34311802
-
AKR1A1
chr1
45550543
45570049
+
AKT2
chr19
40230317
40285536
-
AL121594.1
chr14
35122549
35317474
+
AL136454.1
chr1
192716132
192716653
+
AL358113.1
chr9
69035747
69255187
+
AL645941.2
chr6
32937364
32953122
-
ALDOA
chr16
30064164
30070457
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010226.1
chr5
115602057
115623897
+
AC016876.2
chr17
7581964
7584086
-
AC040162.3
chr16
67882461
67886367
+
AC051619.7
chr15
45200325
45200632
-
AC245014.3
chr1
145281116
145281462
+
AC245884.11
chr19
54308915
54337168
-
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA